Pancreatic Cancer Research

ResearcherChinese University of Hong KongActive in the last 2 years

Chi Hin Wong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9070-193X; OpenAlex author ID A5057403192. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 4 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 10

  1. Genome-Wide and Multi-Omics Analysis Identified DNA-Interacting Circular RNA circFOXK2 as MLL1 Regulator for Histone H3K4 Methylation in Pancreatic Ductal Aden… Co-author DOI 10.1002/advs.77107↗
  2. Exosomal CircGANAB promotes cancer progression and immunotherapy resistance by degrading interacting RNAs and limiting T cell infiltration in pancreatic ductal… Co-author DOI 10.1016/j.drup.2026.101416↗
  3. The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.16286↗
  4. Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma. First author DOI 10.1186/s40364-023-00514-4↗
  5. CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein. Co-author DOI 10.1186/s12943-021-01481-w↗
  6. Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2020.02.038↗
  7. LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jcmgh.2020.06.009↗
  8. A simple and rapid colorimetric detection of serum lncRNA biomarkers for diagnosis of pancreatic cancer. First author DOI 10.1039/c9ra07858d↗
  9. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942. Co-author DOI 10.1158/0008-5472.can-19-3268↗
  10. Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer. Co-author DOI 10.3748/wjg.v22.i31.7046↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yangchao Chen · 10 shared papers, 2016–2026 · strength 1.87
  2. Stephen Lam Chan · 4 shared papers, 2020–2024 · strength 0.64
  3. Ut Kei Lou · 3 shared papers, 2020–2022 · strength 0.48
  4. Chi Han Li · 3 shared papers, 2020–2024 · strength 0.45
  5. Ksh Chok · 1 shared paper, 2026 · strength 0.36
  6. Yinxin Zhu · 2 shared papers, 2020–2023 · strength 0.30
  7. Yan‐Fang Xian · 1 shared paper, 2026 · strength 0.29
  8. Michael Anthony Hollingsworth · 1 shared paper, 2026 · strength 0.29
  9. Bo Li · 1 shared paper, 2024 · strength 0.23
  10. Yuting Liu · 1 shared paper, 2024 · strength 0.23
  11. Jiatong Wang · 1 shared paper, 2023 · strength 0.19
  12. Huiyi Feng · 1 shared paper, 2020 · strength 0.11
  13. Guolin Li · 1 shared paper, 2020 · strength 0.11
  14. Rufu Chen · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.